NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

LC,

Thanks for posting so frequently, but your focus is drifting far from 🌍 … Here on Earth, we are looking forward as the novel DCVax-L cell-based platform technology enters the regulatory phase of its journey. The United States and United Kingdom are largely responsible for developing DCVax-L, and the U.S. and U.K. will lead the novel technology through a global regulatory process.

Combo is King!




https://www.nature.com/articles/s41420-023-01782-7

https://www.jci.org/articles/view/169314






https://www.fda.gov/drugs/our-perspective/50-years-progress-treating-patients-cancer

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

https://www.raps.org/News-and-Articles/News-Articles/2023/9/FDA%E2%80%99s-Califf-Expect-to-see-more-RWE-based-regulato

https://www.raps.org/news-and-articles/news-articles/2023/8/fda-finalizes-guidance-on-real-world-evidence-in-d